Showing results (1-10 of 132) with videos related to
Sort By:
Pageof 14
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Targeting the DNA Damage Response Machinery for Lung Cancer TreatmentKatharigatta N VenugopalaPharmaceuticals (Basel, Switzerland)|October 26, 2024
Pyrimidines: A New Versatile Molecule in the Drug Development Field, Scope, and Future AspectsKatharigatta N Venugopala, Vinuta KamatCurrent Computer-Aided Drug Design|September 20, 2019
2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase InhibitorsOmar Husham Ahmed Al-Attraqchi, Katharigatta N VenugopalaAnti-Cancer Agents in Medicinal Chemistry|September 28, 2016
Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer PropertiesKabange Kasumbwe, Katharigatta N Venugopala, Viresh Mohanlall, et al.Saudi Journal of Biological Sciences|November 26, 2019
Antiglycation, comparative antioxidant potential, phenolic content and yield variation of essential oils from 19 exotic and endemic medicinal plantsF Mahomoodally, Z Aumeeruddy-Elalfi, Katharigatta N Venugopala, et al.Acta Crystallographica. Section E, Crystallographic Communications|August 18, 2018
Crystal structure analysis of [5-(4-meth-oxy-phen-yl)-2-methyl-2<i>H</i>-1,2,3-triazol-4-yl](thio-phen-2-yl)methanoneSubhrajyoti Bhandary, Yarabhally R Girish, Katharigatta N Venugopala, et al.Mini Reviews in Medicinal Chemistry|August 4, 2020
The Potential Application of Novel Drug Delivery Systems for Phytopharmaceuticals and Natural Extracts - Current Status and Future PerspectivesMohamad Fawzi Mahomoodally, Nabeelah Sadeer, Mehtaab Edoo, et al.Plos One|October 17, 2019
Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infectionOsama I Alwassil, Sandeep Chandrashekharappa, Susanta K Nayak, et al.Journal of Medical Virology|September 9, 2020
The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemicsMahmoud Kandeel, Yukio Kitade, Mahmoud Fayez, et al.Pharmaceuticals (Basel, Switzerland)|January 8, 2025
An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling ModulationReetuparna Acharya, Pran Kishore Deb, Katharigatta N Venugopala, et al.Pageof 14